SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : The New QLogic (ANCR) -- Ignore unavailable to you. Want to Upgrade?

To: Ken Richard who wrote (21291)4/5/1999 11:22:00 PM
From: Greg Hull  Respond to of 29386
 
Ken,

<<Also, if memory serves, weren't their shares exercisable in the $8 range?>>

The warrants exercise at $2.50, $5.00, and $10. It's clear they haven't exercised at the last price, and probably not at the lower two either. Someone correct me if they know better, but I'm guessing that INRANGE will not exercise the warrants until they want to sell the common stock. There's no advantage to holding the common over the warrants, is there?

Greg



To: Ken Richard who wrote (21291)4/5/1999 11:23:00 PM
From: eric sahlin  Read Replies (1) | Respond to of 29386
 
Ken-

Inrange's options are exercisable at prices ranging from $2.5 per share to $10 share.

250,000 shares can be purchased at $2.50/share

250,000 shares can be purchased at $5.00/share

250,000 shares can be purchased at $10.00/share

Inrange was able to exercise these options starting on March 24, 1999 and before September 24, 2003.

Eric


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News